Patents by Inventor Chad C. Roue

Chad C. Roue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030204203
    Abstract: Disclosed is an adjustable occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device is removably carried by a deployment catheter. The device may be enlarged or reduced to facilitate optimal placement or removal. Methods are also disclosed.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 30, 2003
    Applicant: ev3 SUNNYVALE, INC., a California corporation
    Inventors: Alexander K. Khairkhahan, Andrew G.C. Frazier, Alan R. Klenk, Marc S. Kreidler, Stewart M. Kume, Darrell H. Ogi, Chad C. Roue, Erik J. van der Burg
  • Publication number: 20030199923
    Abstract: Disclosed is an adjustable occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device is removably carried by a deployment catheter. The device may be enlarged or reduced to facilitate optimal placement or removal. Methods are also disclosed.
    Type: Application
    Filed: May 16, 2003
    Publication date: October 23, 2003
    Applicant: ev3 SUNNYVALE, INC., a California corporation
    Inventors: Alexander K. Khairkhahan, Andrew G.C. Frazier, Alan R. Klenk, Marc S. Kreidler, Stewart M. Kume, Darrell H. Ogi, Chad C. Roue, Erik J. van der Burg
  • Publication number: 20030195555
    Abstract: Disclosed is an adjustable occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device is removably carried by a deployment catheter. The device may be enlarged or reduced to facilitate optimal placement or removal. Methods are also disclosed.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 16, 2003
    Applicant: ev3 SUNNYVALE, INC., a California corporation
    Inventors: Alexander K. Khairkhahan, Andrew G.C. Frazier, Alan R. Klenk, Marc S. Kreidler, Stewart M. Kume, Darrell H. Ogi, Chad C. Roue, Erik J. van der Burg
  • Patent number: 6623493
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: September 23, 2003
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Chad C. Roue
  • Publication number: 20030130689
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Application
    Filed: February 18, 2003
    Publication date: July 10, 2003
    Applicant: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Chad C. Roue
  • Patent number: 6533801
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: March 18, 2003
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Chad C. Roue
  • Publication number: 20030014073
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant is electrically isolated from the electrolytically severable joint by a highly resistive or insulative layer. Such isolation and minimization of the conductive pathway from the placement apparatus to the body's fluids appears to enhance the susceptibility of the electrolytic joint to quick erosion and detachment of the implant from the deployment media. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner.
    Type: Application
    Filed: September 10, 2002
    Publication date: January 16, 2003
    Applicant: SCIMED Life Systems, Inc.
    Inventors: Mehran Bashiri, Michael P. Wallace, Pete Phong Pham, Cong Thach, Chad C. Roue, Joseph C. Eder, Erik T. Engelson
  • Publication number: 20020169377
    Abstract: Disclosed is an apparatus for facilitating access to the left atrium, and specifically the left atrial appendage. The apparatus may comprise a sheath with first and second curved sections that facilitate location of the fossa ovalis and left atrial appendage. The apparatus may further comprise tissue piercing and dilating structures. Methods are also disclosed.
    Type: Application
    Filed: March 15, 2002
    Publication date: November 14, 2002
    Inventors: Alexander K. Khairkhahan, Andrew G.C. Frazier, Alan R. Klenk, Marc S. Kreidler, Stewart M. Kume, Darrell H. Ogi, Chad C. Roue, Erik J. van der Burg
  • Patent number: 6468266
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant is electrically isolated from the electrolytically severable joint by a highly resistive or insulative layer. Such isolation and minimization of the conductive pathway from the placement apparatus to the body's fluids appears to enhance the susceptibility of the electrolytic joint to quick erosion and detachment of the implant from the deployment media. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner.
    Type: Grant
    Filed: August 22, 2000
    Date of Patent: October 22, 2002
    Assignee: SciMed Life Systems, Inc.
    Inventors: Mehran Bashiri, Michael P. Wallace, Pete Phong Pham, Cong Thach, Chad C. Roue, Joseph C. Eder, Erik T. Engelson
  • Patent number: 6458100
    Abstract: Disclosed is a closure catheter, for closing a tissue opening such as an atrial septal defect, patent foreman ovale, or the left atrial appendage of the heart. The closure catheter carries a plurality of tissue anchors, which may be deployed into tissue surrounding the opening, and used to draw the opening closed. Methods are also disclosed.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: October 1, 2002
    Assignee: Appriva Medical, Inc.
    Inventors: Chad C. Roue, Andrew G. C. Frazier, Michael D. Lesh, Erik J. van der Burg
  • Patent number: 6436088
    Abstract: Disclosed is a closure catheter, for patching a tissue opening such as an atrial septal defect, patent foreman ovale, or the left atrial appendage of the heart. The closure catheter carries a deployable patch and a plurality of tissue anchors, which may be deployed to secure the patch to surrounding tissue. Methods are also disclosed.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: August 20, 2002
    Assignee: Appriva Medical, Inc.
    Inventors: Andrew G. C. Frazier, Michael D. Lesh, Chad C. Roue, Erik J. van der Burg
  • Publication number: 20020111647
    Abstract: Disclosed is an adjustable occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device is removably carried by a deployment catheter. The device may be enlarged or reduced to facilitate optimal placement or removal. Methods are also disclosed.
    Type: Application
    Filed: October 19, 2001
    Publication date: August 15, 2002
    Inventors: Alexander K. Khairkhahan, Andrew G.C. Frazier, Alan R. Klenk, Marc s. Kreidler, Stewart M. Kume, Darrell H. Ogi, Chad C. Roue, Erik J. van der Burg
  • Patent number: 6425914
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant component is at least partially covered with a highly resistive or insulative covering. The highly resistive or insulative layer or covering appears to enhance the susceptibility of the electrolytic joint to quick erosion and thus detachment of the implant. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner. The implant may be independently coated with insulative or resistive material or may be formed using a material with such as tantalum, which forms such an insulator or resistor in situ.
    Type: Grant
    Filed: September 21, 2000
    Date of Patent: July 30, 2002
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Mehran Bashiri, Chad C. Roue
  • Patent number: 6419669
    Abstract: Disclosed is a closure catheter, for patching a tissue opening such as an atrial septal defect, patent foreman ovale, or the left atrial appendage of the heart. The closure catheter carries a deployable patch and a plurality of tissue anchors, which may be deployed to secure the patch to surrounding tissue. Methods are also disclosed.
    Type: Grant
    Filed: November 22, 1999
    Date of Patent: July 16, 2002
    Assignee: Appriva Medical, Inc.
    Inventors: Andrew G. C. Frazier, Michael D. Lesh, Chad C. Roue, Erik J. van der Burg
  • Publication number: 20020058962
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Application
    Filed: November 27, 2001
    Publication date: May 16, 2002
    Inventors: Michael P. Wallace, Chad C. Roue
  • Patent number: 6371972
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: April 16, 2002
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Chad C. Roue
  • Patent number: 6350270
    Abstract: An improved aneurysm liner is used for treating an aneurysm in a parent vessel. The parent vessel defines a lumen. The aneurysm includes a neck and an inner wall defining a cavity in fluid communication with the lumen. The liner device is configured for deployment within the cavity. The device includes an extender inside an expandable aneurysm liner. The proximal pusher end of the extender receives force from a distal end of a delivery catheter for maneuvering the device into a deployment position. The device is arranged such that, when deployed within the cavity, the liner is expanded to fill the cavity. In treating an aneurysm, the liner device is directed to the aneurysm site by a guidewire that extends through the extender. Upon removal of the guidewire, the extender is released within the liner and the liner is expanded to fill the cavity.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: February 26, 2002
    Assignee: Scimed Life Systems, Inc.
    Inventor: Chad C. Roue
  • Publication number: 20010056281
    Abstract: This device is an apparatus for endovascular occlusion through the formation of thrombi in arteries, veins, aneurysms, vascular malformations, and arteriovenous fistulas. In particular, the device includes multiple vaso-occlusive members connected by electrolytically disintegratible links. Each link connects to the vaso-occlusive member by electrically insulative and conductive joints on opposite ends of the link. The vaso-occlusive members are delivered through a delivery catheter having on its distal end an electrode for electrical contact with the vaso-occlusive member. Upon application of an electrical current through the electrode to the vaso-occlusive member and its conductive joint to the electrolytically disintegratible link, the link disintegrates, selectively detaching the desired number of vaso-occlusive members into the target thrombus formation site.
    Type: Application
    Filed: August 24, 2001
    Publication date: December 27, 2001
    Inventors: Michael P. Wallace, Chad C. Roue
  • Patent number: 6328727
    Abstract: Disclosed is an anastomosis catheter, for achieving a tissue to tissue or synthetic graft to tissue attachment. The catheter includes a plurality of deployable tissue anchors, which may be laterally deployed into surrounding tissue. The anchors may be used to achieve end to end or end to side anastomoses. Methods are also disclosed.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: December 11, 2001
    Assignee: Appriva Medical, Inc.
    Inventors: Andrew G. C. Frazier, Michael D. Lesh, Chad C. Roue, Erik J. van der Burg
  • Publication number: 20010049492
    Abstract: Disclosed is an anastomosis catheter, for achieving a tissue to tissue or synthetic graft to tissue attachment. The catheter includes a plurality of deployable tissue anchors, which may be laterally deployed into surrounding tissue. The anchors may be used to achieve end to end or end to side anastomoses. Methods are also disclosed.
    Type: Application
    Filed: July 11, 2001
    Publication date: December 6, 2001
    Inventors: Andrew G.C. Frazier, Michael D. Lesh, Chad C. Roue, Erik J. Van Der Burg